Marshall Wace, LLP Sanara Med Tech Inc. Transaction History
Marshall Wace, LLP
- $90.8 Billion
- Q3 2025
A detailed history of Marshall Wace, LLP transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 66,073 shares of SMTI stock, worth $1.42 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66,073
Previous 71,511
7.6%
Holding current value
$1.42 Million
Previous $2.03 Million
1.58%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SMTI
# of Institutions
56Shares Held
1.11MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY197KShares$4.24 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA182KShares$3.91 Million0.0% of portfolio
-
Stonebridge Wealth Management, LLC Oak Brook, IL115KShares$2.46 Million3.12% of portfolio
-
Geode Capital Management, LLC Boston, MA78.5KShares$1.69 Million0.0% of portfolio
-
State Street Corp Boston, MA61.6KShares$1.32 Million0.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $179M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...